NCOA3 and breast carcinoma: Nuclear steroid receptor coactivator-3 (SRC-3/AIB1/NCOA3) was originally identified as a gene amplified in nearly 10% of breast cancers [1] but has been shown to be overexpressed in 50–60% of cases with weak to absent expression in normal mammary tissue [2].